Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.
Zimmer Biomet has gained 510(k) clearance from the US Food and Drug Administration (FDA) for the OsseoFit Stemless Shoulder System. Designed for total shoulder replacement, the implant is tailored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback